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To the Editor  
I have read with great interest a case report authored by Dr Giordano and colleagues 
published in this journal recently [1]. This report documented, for the first time, that renal 
denervation was successfully performed in a renal artery with a significant stenosis at the 
proximal tract [1]. The researchers crossed the lesion with the ablation catheter and then 
performed 6 ablation runs distally to the stenotic lesion. The pre-existing renal artery stenosis 
was stable within 6 months after the procedure. This case report may be important because 
renal artery stenosis is common in hypertensive patients. For example, a study reported that 7% 
of hypertensive patients have angiographically significant renal artery stenosis (lumen 
narrowing  ≥  50%) [2]. 
However, it is still a concern to perform renal denervation in the renal artery with significant 
stenosis for the following reasons. (1) It has been reported that renal artery stenosis can occur 
after the procedure in up to 4.3% of hypertensive patients who did not have this complication 
before the procedure [3]. Therefore, caution should be taken when performing renal 
denervation in patients complicated with renal artery stenosis. (2) Atherosclerosis accounts 
for approximately 90% of the cases of renal artery stenosis in clinics [4]. Although renal 
denervation in this case report was uneventful, it is possible that the renal denervation 
catheter may cause renal atherosclerotic rupture, which may lead to cholesterol embolization 
and consequently renal failure [5]. (3) The authors mentioned that “in the worst case scenario 
that a complication occurs during the procedure, stenting can be easily performed”. However, 
stenting is not always a safe approach. For example, it has been reported that stenting of the 
renal artery can lead to stent thrombosis and sometimes death [6]. (4) The effect of renal 
denervation on lowering blood pressure is controversial. Although a large number of clinical 
studies showed that renal denervation decreased blood pressure, Medtronic released the 
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results of the Symplicity HTN-3 trial on 9 January 2014 which showed that renal denervation 
did not lower blood pressure compared with the sham control at 6 months. 
Therefore, it is better to follow the patient selection criteria used in the Symplicity HTN-1 
and HTN-2 trials [7, 8] to avoid performing renal denervation in renal arteries with 
significant stenosis both in clinical practice and in clinical trials investigating the effect of 
renal denervation on hypertension or non-hypertension indications, e.g. diabetes [9].  
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